These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 3200827

  • 1. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
    Gaynor RB, Kuwabara MD, Wu FK, Garcia JA, Harrich D, Briskin M, Wall R, Sigman DS.
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9406-10. PubMed ID: 3200827
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
    Maciaszek JW, Talmage DA, Viglianti GA.
    J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.
    Wu F, Garcia J, Mitsuyasu R, Gaynor R.
    J Virol; 1988 Jan; 62(1):218-25. PubMed ID: 3257103
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
    Verhoef K, Sanders RW, Fontaine V, Kitajima S, Berkhout B.
    J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The kappa B enhancer motifs in human immunodeficiency virus type 1 and simian virus 40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-kappa B-independent activation of the kappa B motif.
    Phares W, Franza BR, Herr W.
    J Virol; 1992 Dec; 66(12):7490-8. PubMed ID: 1331533
    [Abstract] [Full Text] [Related]

  • 10. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
    Wu FK, Garcia JA, Harrich D, Gaynor RB.
    EMBO J; 1988 Jul; 7(7):2117-30. PubMed ID: 3138113
    [Abstract] [Full Text] [Related]

  • 11. Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.
    Phares W, Herr W.
    J Virol; 1991 May; 65(5):2200-10. PubMed ID: 1850006
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
    Speck NA, Renjifo B, Hopkins N.
    J Virol; 1990 Feb; 64(2):543-50. PubMed ID: 2104942
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription.
    Dasgupta P, Saikumar P, Reddy CD, Reddy EP.
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8090-4. PubMed ID: 2236022
    [Abstract] [Full Text] [Related]

  • 18. Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence.
    Gimble JM, Duh E, Ostrove JM, Gendelman HE, Max EE, Rabson AB.
    J Virol; 1988 Nov; 62(11):4104-12. PubMed ID: 2845125
    [Abstract] [Full Text] [Related]

  • 19. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V, Ebbesen P, Thomas RA, Zacharova V, Goustin AS.
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [Abstract] [Full Text] [Related]

  • 20. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.
    Cross SL, Halden NF, Lenardo MJ, Leonard WJ.
    Science; 1989 Apr 28; 244(4903):466-9. PubMed ID: 2497520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.